- Home
- News
- Forum
- Sports
- Features
- Arts
- Business
- Obituaries
- Comics
- Gallery
- Classifieds
- Commentary
- Advertisers
- Contact Us
4,025
1,551
Marrone raises $25.4M in Series C financing
Davis-based Marrone Bio Innovations Inc. has closed a $25.4 million private round of financing with three new investors and re-investment of existing investors, the company announced this week.
New investors include Syngenta Ventures, Mitsui Global Investment, and a family investment trust. Existing investors include Stuart Mill Venture Partners, Contrarian Group, Saffron Hill Ventures, One Earth Capital, Clean Pacific Ventures and Calvert Social Ventures, in addition to several individuals. Contrarian Group’s CFO, Tim Fogarty, has joined the Board.
The financing is being used for expanding global sales of Regalia Biofungicide, launching Zequanox and other pipeline products upon EPA approval and development of new nematicides, herbicides and fungicides from the discovery screen.
“We are very pleased to receive investment from new investors and to have the support of our existing investors. Their size and prominence as well as the amount funded recognize our rapid progress in the marketplace, unsurpassed product pipeline, and unique discovery capability,” said Pam Marrone, MBI’s founder and CEO.
MBI discovers, develops and markets effective and environmentally responsible natural products that fill unmet needs for weed, plant disease and pest management. For more information, visit www.marronebioinnovations.com.
Comments
Recent Posts
- Herd has too much for Devil softballers
- Dominic Fannjiang DHS boys volleyball vs. Elk Grove file photo
- DHS boys drop another Delta League match
- DYSA 10U roundup: Blue Diamonds’ slugfest win highlights close week of games
- Avangeline Turner, Paige Jenness (Yellow Jackets) and Elizabeth Barger (Lightning) DYSA 10U photo
